Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

EPOCH regimen

View Patient Information

A chemotherapy regimen consisting of etoposide, prednisone, vincristine (Oncovin), cyclophosphamide and doxorubicin hydrochloride (hydroxydaunorubicin hydrochloride), which may be used in combination with rituximab (R-EPOCH) for the treatment of various aggressive B-cell and T-cell non-Hodgkin lymphomas.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	DA-EPOCH DA-EPOCH regimen dose-adjusted etoposide/vincristine/doxorubicin/cyclophosphamide/prednisone regimen EPOCH etoposide-prednisone-Oncovin-cyclophosphamide-hydroxydaunorubicin regimen etoposide/prednisone/Oncovin/cyclophosphamide/hydroxydaunorubicin regimen

EPOCH regimen

Search NCI's Drug Dictionary